In the words of the investigators.
These are principal investigators and scientific directors at the cooperative groups and academic centres that run their trials on WIDEN, speaking about the part of the work they rely on most: timely, blinded, independent central review.
Named peers, on the record.
Reproduced in full and unedited, as first published.
WIDEN is a great platform to use for imaging in clinical trials. It works across time zones for international trials. As a reporter, it’s easy to access, integrates with my preferred local software and I can easily enter my results. It contacts the Clinician responsible for the patient directly and offers a feature for urgent medical communication. Any issues and I have found the WIDEN team to be very receptive.
Since 2010, the Polish Lymphoma Research Group is an active user of Dixit and their WIDEN platform, that enabled us to start and carry out Observational Study on the role of very early interim PET results during ABVD chemotherapy of patients with Hodgkin Lymphoma. The study requires reviewing of all interim PET studies by the independent Panel of Reviewers. Such a panel, consisting of the Polish and Italian nuclear medicine specialists was established. All reviewers have the access to anonymized PET scans loaded to the WIDEN platform by local PET centers in Poland. The process requires some basic computer skills and is feasible for all even inexperienced users. It allows comparing the concordance between reviewers and identifying cases requiring further discussion. Without WIDEN our study would never gain any scientific value.
The International Extranodal Lymphoma Study Group is using Dixit and the WIDEN platform in several ongoing international clinical trials, in which the timely central review of PET scans is a most critical step. The WIDEN software fully meets our needs and completely fulfills our expectations. WIDEN has become an essential support to our research programs.
Our department is using Dixit and the WIDEN platform in an ongoing international clinical trial, in which the timely central review of PET scans is a most critical step. The WIDEN software fully meets our needs and completely fulfills our expectations. WIDEN has become an essential support to our research programs.
The groups behind the trials.
Cooperative groups and academic centres whose studies run on WIDEN.
Put the same review process behind your endpoints.
The central review these investigators describe is the one we would run for your study — the same platform, the same governance, the same audit trail.